Compedia Global Healthcare

AI Platform for Mental Health, Trauma, Autism, ADHD, and Chronic Care Support

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2026 by Roger Bishop, Ilan Goldberg, and Gil Ilutowich, Compedia Global Healthcare operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing an AI platform for mental health and chronic care support.

Business overview

Compedia Global Healthcare is a digital health technology company that develops a B2B2C software platform for clinical management and remote delivery of mental, emotional, neurodevelopmental, trauma-related, and chronic care interventions. Its core technology integrates structured digital treatment programs, AI-guided navigation, patient onboarding, and longitudinal engagement tracking with provider-facing analytics dashboards. The platform serves healthcare systems, insurers, schools, and specialized clinics, enabling them to prescribe and monitor remote or hybrid care workflows, particularly within the Health Tech & Life Sciences sector.

Company Intelligence Q&A

What is Compedia Global Healthcare's primary product?
Compedia Global Healthcare's primary product is NES (Neuro-Emotional Support), a software platform designed for clinical management and remote delivery of mental, emotional, neurodevelopmental, trauma-related, and chronic care interventions.
When was Compedia Global Healthcare founded?
Compedia Global Healthcare was founded in January 2026.
Who are the founders of Compedia Global Healthcare?
The founders of Compedia Global Healthcare are Roger Bishop, Ilan Goldberg, and Gil Ilutowich.
What is the current product stage of Compedia Global Healthcare?
Compedia Global Healthcare's product is currently in the Clinical Trial stage, with its NES (Neuro-Emotional Support) platform undergoing validation for clinical management and remote delivery of mental and chronic care interventions.
Which markets does Compedia Global Healthcare target?
Compedia Global Healthcare primarily targets the United States market.